These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 29589172)
1. Utilization of phage display to identify antigenic regions in the PCV2 capsid protein for the evaluation of serological responses in mice and pigs. Santos MR; Assao VS; Santos FAA; Salgado RL; Carneiro AP; Fietto JLR; Bressan GC; de Almeida MR; Lobato ZIP; Ueira-Veira C; Goulart LR; Silva-Júnior A Arch Virol; 2018 Jul; 163(7):1877-1887. PubMed ID: 29589172 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity Evaluation of Modified Adenovirus Vaccines Expressing Porcine Circovirus Type 2 Capsid Protein in Pigs. Li D; Xu D; Wang Z; Du Q; Chang L; Zhao X; Huang Y; Tong D Viral Immunol; 2017 Mar; 30(2):111-119. PubMed ID: 27996636 [TBL] [Abstract][Full Text] [Related]
3. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice. Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504 [TBL] [Abstract][Full Text] [Related]
5. Epitope screening of the PCV2 Cap protein by use of a random peptide-displayed library and polyclonal antibody. Ge M; Yan A; Luo W; Hu YF; Li RC; Jiang DL; Yu XL Virus Res; 2013 Oct; 177(1):103-7. PubMed ID: 23845304 [TBL] [Abstract][Full Text] [Related]
6. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts. Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739 [TBL] [Abstract][Full Text] [Related]
7. Early antibody responses map to non-protective, PCV2 capsid protein epitopes. Ilha M; Nara P; Ramamoorthy S Virology; 2020 Jan; 540():23-29. PubMed ID: 31734380 [TBL] [Abstract][Full Text] [Related]
8. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs. Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544 [TBL] [Abstract][Full Text] [Related]
9. Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2. Shang SB; Jin YL; Jiang XT; Zhou JY; Zhang X; Xing G; He JL; Yan Y Mol Immunol; 2009 Jan; 46(3):327-34. PubMed ID: 19059648 [TBL] [Abstract][Full Text] [Related]
10. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B. Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366 [TBL] [Abstract][Full Text] [Related]
11. Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2. Huang LP; Lu YH; Wei YW; Guo LJ; Liu CM BMC Microbiol; 2011 Aug; 11():188. PubMed ID: 21859462 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs. Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834 [TBL] [Abstract][Full Text] [Related]
13. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets. Zhang H; Qian P; Peng B; Shi L; Chen H; Li X Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115 [TBL] [Abstract][Full Text] [Related]
14. Peptides mimicking viral proteins of porcine circovirus type 2 were profiled by the spectrum of mouse anti-PCV2 antibodies. Hung LC; Yang CY; Cheng IC BMC Immunol; 2017 May; 18(1):25. PubMed ID: 28506209 [TBL] [Abstract][Full Text] [Related]
15. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice. Jung BK; Kim HR; Lee YH; Jang H; Chang KS J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882 [TBL] [Abstract][Full Text] [Related]
17. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice. Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706 [TBL] [Abstract][Full Text] [Related]
18. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli. Wu PC; Chen TY; Chi JN; Chien MS; Huang C J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354 [TBL] [Abstract][Full Text] [Related]
19. Genetic and immunogenicity analysis of porcine circovirus type 2 strains isolated in central China. Liu C; Liu Y; Chen H; Feng H; Chen Y; Wang Y; Wang J; Liu D; Deng R; Zhang G Arch Virol; 2018 Apr; 163(4):937-946. PubMed ID: 29305646 [TBL] [Abstract][Full Text] [Related]
20. Capsid proteins from PCV2a genotype confer greater protection against a PCV2b strain than those from PCV2b genotype in pigs: evidence for PCV2b strains becoming more predominant than PCV2a strains from 2000 to 2010s. Huang L; Wang Y; Wei Y; Chen D; Liu D; Du W; Xia D; Wu H; Feng L; Liu C Appl Microbiol Biotechnol; 2016 Jul; 100(13):5933-43. PubMed ID: 27020283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]